1,ABBV,AbbVie Inc.,https://www.nasdaq.com/market-activity/stocks/ABBV/news-headlines
2,ABEO,Abeona Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/ABEO/news-headlines
3,ABIO,ARCA biopharma Inc.,https://www.nasdaq.com/market-activity/stocks/ABIO/news-headlines
4,ABUS,Arbutus Biopharma Corporation,https://www.nasdaq.com/market-activity/stocks/ABUS/news-headlines
5,ACAD,ACADIA Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/ACAD/news-headlines
6,ACER,Acer Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/ACER/news-headlines
7,ACET,Adicet Bio Inc.,https://www.nasdaq.com/market-activity/stocks/ACET/news-headlines
8,ACHV,Achieve Life Sciences Inc.,https://www.nasdaq.com/market-activity/stocks/ACHV/news-headlines
9,ACIU,AC Immune SA,https://www.nasdaq.com/market-activity/stocks/ACIU/news-headlines
10,ACOR,Acorda Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/ACOR/news-headlines
11,ACRS,Aclaris Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/ACRS/news-headlines
12,ACRX,AcelRx Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/ACRX/news-headlines
13,ACST,Acasti Pharma Inc.,https://www.nasdaq.com/market-activity/stocks/ACST/news-headlines
14,ADAP,Adaptimmune Therapeutics plc,https://www.nasdaq.com/market-activity/stocks/ADAP/news-headlines
15,ADCT,ADC Therapeutics SA,https://www.nasdaq.com/market-activity/stocks/ADCT/news-headlines
16,ADIL,Adial Pharmaceuticals Inc,https://www.nasdaq.com/market-activity/stocks/ADIL/news-headlines
17,ADMA,ADMA Biologics Inc,https://www.nasdaq.com/market-activity/stocks/ADMA/news-headlines
18,ADMP,Adamis Pharmaceuticals Corporation,https://www.nasdaq.com/market-activity/stocks/ADMP/news-headlines
19,ADMS,Adamas Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/ADMS/news-headlines
20,ADTX,ADiTx Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/ADTX/news-headlines
21,ADVM,Adverum Biotechnologies Inc.,https://www.nasdaq.com/market-activity/stocks/ADVM/news-headlines
22,ADXS,Advaxis Inc.,https://www.nasdaq.com/market-activity/stocks/ADXS/news-headlines
23,AERI,Aerie Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/AERI/news-headlines
24,AEZS,Aeterna Zentaris Inc.,https://www.nasdaq.com/market-activity/stocks/AEZS/news-headlines
25,AFMD,Affimed N.V.,https://www.nasdaq.com/market-activity/stocks/AFMD/news-headlines
26,AGEN,Agenus Inc.,https://www.nasdaq.com/market-activity/stocks/AGEN/news-headlines
27,AGIO,Agios Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/AGIO/news-headlines
28,AGLE,Aeglea BioTherapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/AGLE/news-headlines
29,AGRX,Agile Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/AGRX/news-headlines
30,AGTC,Applied Genetic Technologies Corporation,https://www.nasdaq.com/market-activity/stocks/AGTC/news-headlines
31,AIM,AIM ImmunoTech Inc.,https://www.nasdaq.com/market-activity/stocks/AIM/news-headlines
32,AIMT,Aimmune Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/AIMT/news-headlines
33,AKBA,Akebia Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/AKBA/news-headlines
34,AKCA,Akcea Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/AKCA/news-headlines
35,AKER,Akers Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/AKER/news-headlines
36,AKRO,Akero Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/AKRO/news-headlines
37,AKTX,Akari Therapeutics Plc,https://www.nasdaq.com/market-activity/stocks/AKTX/news-headlines
38,AKUS,Akouos Inc.,https://www.nasdaq.com/market-activity/stocks/AKUS/news-headlines
39,ALBO,Albireo Pharma Inc.,https://www.nasdaq.com/market-activity/stocks/ALBO/news-headlines
40,ALDX,Aldeyra Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/ALDX/news-headlines
41,ALEC,Alector Inc.,https://www.nasdaq.com/market-activity/stocks/ALEC/news-headlines
42,ALIM,Alimera Sciences Inc.,https://www.nasdaq.com/market-activity/stocks/ALIM/news-headlines
43,ALKS,Alkermes plc,https://www.nasdaq.com/market-activity/stocks/ALKS/news-headlines
44,ALLK,Allakos Inc.,https://www.nasdaq.com/market-activity/stocks/ALLK/news-headlines
45,ALLO,Allogene Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/ALLO/news-headlines
46,ALNA,Allena Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/ALNA/news-headlines
47,ALNY,Alnylam Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/ALNY/news-headlines
48,ALPN,Alpine Immune Sciences Inc.,https://www.nasdaq.com/market-activity/stocks/ALPN/news-headlines
49,ALRN,Aileron Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/ALRN/news-headlines
50,ALT,Altimmune Inc.,https://www.nasdaq.com/market-activity/stocks/ALT/news-headlines
51,ALVR,AlloVir Inc.,https://www.nasdaq.com/market-activity/stocks/ALVR/news-headlines
52,ALXN,Alexion Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/ALXN/news-headlines
53,ALXO,ALX Oncology Holdings Inc.,https://www.nasdaq.com/market-activity/stocks/ALXO/news-headlines
54,AMAG,AMAG Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/AMAG/news-headlines
55,AMGN,Amgen Inc.,https://www.nasdaq.com/market-activity/stocks/AMGN/news-headlines
56,AMPE,Ampio Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/AMPE/news-headlines
57,AMPH,Amphastar Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/AMPH/news-headlines
58,AMRN,Amarin Corporation plc,https://www.nasdaq.com/market-activity/stocks/AMRN/news-headlines
59,AMRX,Amneal Pharmaceuticals Inc. Class A,https://www.nasdaq.com/market-activity/stocks/AMRX/news-headlines
60,AMTI,Applied Molecular Transport Inc.,https://www.nasdaq.com/market-activity/stocks/AMTI/news-headlines
61,ANAB,AnaptysBio Inc.,https://www.nasdaq.com/market-activity/stocks/ANAB/news-headlines
62,ANCN,Anchiano Therapeutics Ltd.,https://www.nasdaq.com/market-activity/stocks/ANCN/news-headlines
63,ANIK,Anika Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/ANIK/news-headlines
64,ANIP,ANI Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/ANIP/news-headlines
65,ANIX,Anixa Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/ANIX/news-headlines
66,ANNX,Annexon Inc.,https://www.nasdaq.com/market-activity/stocks/ANNX/news-headlines
67,ANVS,Annovis Bio Inc.,https://www.nasdaq.com/market-activity/stocks/ANVS/news-headlines
68,APLS,Apellis Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/APLS/news-headlines
69,APLT,Applied Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/APLT/news-headlines
70,APRE,Aprea Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/APRE/news-headlines
71,APTO,Aptose Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/APTO/news-headlines
72,APTX,Aptinyx Inc.,https://www.nasdaq.com/market-activity/stocks/APTX/news-headlines
73,APVO,Aptevo Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/APVO/news-headlines
74,AQST,Aquestive Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/AQST/news-headlines
75,ARAV,Aravive Inc.,https://www.nasdaq.com/market-activity/stocks/ARAV/news-headlines
76,ARCT,Arcturus Therapeutics Holdings Inc.,https://www.nasdaq.com/market-activity/stocks/ARCT/news-headlines
77,ARDS,Aridis Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/ARDS/news-headlines
78,ARDX,Ardelyx Inc.,https://www.nasdaq.com/market-activity/stocks/ARDX/news-headlines
79,ARGX,argenx SE,https://www.nasdaq.com/market-activity/stocks/ARGX/news-headlines
80,ARMP,Armata Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/ARMP/news-headlines
81,ARNA,Arena Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/ARNA/news-headlines
82,ARPO,Aerpio Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/ARPO/news-headlines
83,ARQT,Arcutis Biotherapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/ARQT/news-headlines
84,ARVN,Arvinas Inc.,https://www.nasdaq.com/market-activity/stocks/ARVN/news-headlines
85,ARWR,Arrowhead Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/ARWR/news-headlines
86,ASLN,ASLAN Pharmaceuticals Limited,https://www.nasdaq.com/market-activity/stocks/ASLN/news-headlines
87,ASMB,Assembly Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/ASMB/news-headlines
88,ASND,Ascendis Pharma A/S,https://www.nasdaq.com/market-activity/stocks/ASND/news-headlines
89,ASRT,Assertio Holdings Inc.,https://www.nasdaq.com/market-activity/stocks/ASRT/news-headlines
90,ATHA,Athira Pharma Inc.,https://www.nasdaq.com/market-activity/stocks/ATHA/news-headlines
91,ATHE,Alterity Therapeutics Limited,https://www.nasdaq.com/market-activity/stocks/ATHE/news-headlines
92,ATHX,Athersys Inc.,https://www.nasdaq.com/market-activity/stocks/ATHX/news-headlines
93,ATNM,Actinium Pharmaceuticals Inc. (Delaware),https://www.nasdaq.com/market-activity/stocks/ATNM/news-headlines
94,ATNX,Athenex Inc.,https://www.nasdaq.com/market-activity/stocks/ATNX/news-headlines
95,ATOS,Atossa Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/ATOS/news-headlines
96,ATRA,Atara Biotherapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/ATRA/news-headlines
97,ATRS,Antares Pharma Inc.,https://www.nasdaq.com/market-activity/stocks/ATRS/news-headlines
98,ATXI,Avenue Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/ATXI/news-headlines
99,AUPH,Aurinia Pharmaceuticals Inc,https://www.nasdaq.com/market-activity/stocks/AUPH/news-headlines
100,AUTL,Autolus Therapeutics plc,https://www.nasdaq.com/market-activity/stocks/AUTL/news-headlines
101,AVDL,Avadel Pharmaceuticals plc,https://www.nasdaq.com/market-activity/stocks/AVDL/news-headlines
102,AVEO,AVEO Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/AVEO/news-headlines
103,AVRO,AVROBIO Inc.,https://www.nasdaq.com/market-activity/stocks/AVRO/news-headlines
104,AVXL,Anavex Life Sciences Corp.,https://www.nasdaq.com/market-activity/stocks/AVXL/news-headlines
105,AXGN,Axogen Inc.,https://www.nasdaq.com/market-activity/stocks/AXGN/news-headlines
106,AXGT,Axovant Gene Therapies Ltd.,https://www.nasdaq.com/market-activity/stocks/AXGT/news-headlines
107,AXLA,Axcella Health Inc.,https://www.nasdaq.com/market-activity/stocks/AXLA/news-headlines
108,AXSM,Axsome Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/AXSM/news-headlines
109,AYLA,Ayala Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/AYLA/news-headlines
110,AZN,AstraZeneca PLC,https://www.nasdaq.com/market-activity/stocks/AZN/news-headlines
111,AZRX,AzurRx BioPharma Inc.,https://www.nasdaq.com/market-activity/stocks/AZRX/news-headlines
112,BBI,"Brickell Biotech, Inc.",https://www.nasdaq.com/market-activity/stocks/BBI/news-headlines
113,BBIO,BridgeBio Pharma Inc.,https://www.nasdaq.com/market-activity/stocks/BBIO/news-headlines
114,BCDA,BioCardia Inc.,https://www.nasdaq.com/market-activity/stocks/BCDA/news-headlines
115,BCEL,Atreca Inc.,https://www.nasdaq.com/market-activity/stocks/BCEL/news-headlines
116,BCLI,Brainstorm Cell Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/BCLI/news-headlines
117,BCRX,BioCryst Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/BCRX/news-headlines
118,BCYC,Bicycle Therapeutics plc,https://www.nasdaq.com/market-activity/stocks/BCYC/news-headlines
119,BDSI,BioDelivery Sciences International Inc.,https://www.nasdaq.com/market-activity/stocks/BDSI/news-headlines
120,BDTX,Black Diamond Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/BDTX/news-headlines
121,BEAM,Beam Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/BEAM/news-headlines
122,BFRA,Biofrontera AG,https://www.nasdaq.com/market-activity/stocks/BFRA/news-headlines
123,BGNE,BeiGene Ltd.,https://www.nasdaq.com/market-activity/stocks/BGNE/news-headlines
124,BHC,Bausch Health Companies Inc.,https://www.nasdaq.com/market-activity/stocks/BHC/news-headlines
125,BHVN,Biohaven Pharmaceutical Holding Company Ltd.,https://www.nasdaq.com/market-activity/stocks/BHVN/news-headlines
126,BIIB,Biogen Inc.,https://www.nasdaq.com/market-activity/stocks/BIIB/news-headlines
127,BLCM,Bellicum Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/BLCM/news-headlines
128,BLPH,Bellerophon Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/BLPH/news-headlines
129,BLRX,BioLineRx Ltd.,https://www.nasdaq.com/market-activity/stocks/BLRX/news-headlines
130,BLU,BELLUS Health Inc.,https://www.nasdaq.com/market-activity/stocks/BLU/news-headlines
131,BLUE,bluebird bio Inc.,https://www.nasdaq.com/market-activity/stocks/BLUE/news-headlines
132,BMRN,BioMarin Pharmaceutical Inc.,https://www.nasdaq.com/market-activity/stocks/BMRN/news-headlines
133,BMY,Bristol-Myers Squibb Company,https://www.nasdaq.com/market-activity/stocks/BMY/news-headlines
134,BNTC,Benitec Biopharma Inc.,https://www.nasdaq.com/market-activity/stocks/BNTC/news-headlines
135,BNTX,BioNTech SE,https://www.nasdaq.com/market-activity/stocks/BNTX/news-headlines
136,BPMC,Blueprint Medicines Corporation,https://www.nasdaq.com/market-activity/stocks/BPMC/news-headlines
137,BPTH,Bio-Path Holdings Inc.,https://www.nasdaq.com/market-activity/stocks/BPTH/news-headlines
138,BSGM,BioSig Technologies Inc.,https://www.nasdaq.com/market-activity/stocks/BSGM/news-headlines
139,BSTC,BioSpecifics Technologies Corp,https://www.nasdaq.com/market-activity/stocks/BSTC/news-headlines
140,BTAI,BioXcel Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/BTAI/news-headlines
141,BVXV,BiondVax Pharmaceuticals Ltd.,https://www.nasdaq.com/market-activity/stocks/BVXV/news-headlines
142,BXRX,Baudax Bio Inc.,https://www.nasdaq.com/market-activity/stocks/BXRX/news-headlines
143,BYSI,BeyondSpring Inc.,https://www.nasdaq.com/market-activity/stocks/BYSI/news-headlines
144,CABA,Cabaletta Bio Inc.,https://www.nasdaq.com/market-activity/stocks/CABA/news-headlines
145,CALA,Calithera Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/CALA/news-headlines
146,CALT,Calliditas Therapeutics AB,https://www.nasdaq.com/market-activity/stocks/CALT/news-headlines
147,CANF,Can-Fite Biopharma Ltd Sponsored ADR (Israel),https://www.nasdaq.com/market-activity/stocks/CANF/news-headlines
148,CAPR,Capricor Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/CAPR/news-headlines
149,CARA,Cara Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/CARA/news-headlines
150,CASI,CASI Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/CASI/news-headlines
151,CATB,Catabasis Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/CATB/news-headlines
152,CBAY,CymaBay Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/CBAY/news-headlines
153,CBIO,Catalyst Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/CBIO/news-headlines
154,CBLI,Cleveland BioLabs Inc.,https://www.nasdaq.com/market-activity/stocks/CBLI/news-headlines
155,CCCC,C4 Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/CCCC/news-headlines
156,CCXI,ChemoCentryx Inc.,https://www.nasdaq.com/market-activity/stocks/CCXI/news-headlines
157,CDAK,Codatek Corp.,https://www.nasdaq.com/market-activity/stocks/CDAK/news-headlines
158,CDMO,Avid Bioservices Inc.,https://www.nasdaq.com/market-activity/stocks/CDMO/news-headlines
159,CDTX,Cidara Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/CDTX/news-headlines
160,CDXS,Codexis Inc.,https://www.nasdaq.com/market-activity/stocks/CDXS/news-headlines
161,CERC,Cerecor Inc.,https://www.nasdaq.com/market-activity/stocks/CERC/news-headlines
162,CERS,Cerus Corporation,https://www.nasdaq.com/market-activity/stocks/CERS/news-headlines
163,CFRX,ContraFect Corporation,https://www.nasdaq.com/market-activity/stocks/CFRX/news-headlines
164,CGEN,Compugen Ltd.,https://www.nasdaq.com/market-activity/stocks/CGEN/news-headlines
165,CHMA,Chiasma Inc.,https://www.nasdaq.com/market-activity/stocks/CHMA/news-headlines
166,CHRS,Coherus BioSciences Inc.,https://www.nasdaq.com/market-activity/stocks/CHRS/news-headlines
167,CKPT,Checkpoint Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/CKPT/news-headlines
168,CLBS,Caladrius Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/CLBS/news-headlines
169,CLDX,Celldex Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/CLDX/news-headlines
170,CLLS,Cellectis S.A.,https://www.nasdaq.com/market-activity/stocks/CLLS/news-headlines
171,CLRB,Cellectar Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/CLRB/news-headlines
172,CLSD,Clearside Biomedical Inc.,https://www.nasdaq.com/market-activity/stocks/CLSD/news-headlines
173,CLSN,Celsion Corporation,https://www.nasdaq.com/market-activity/stocks/CLSN/news-headlines
174,CLVS,Clovis Oncology Inc.,https://www.nasdaq.com/market-activity/stocks/CLVS/news-headlines
175,CMPI,Checkmate Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/CMPI/news-headlines
176,CMRX,Chimerix Inc.,https://www.nasdaq.com/market-activity/stocks/CMRX/news-headlines
177,CNCE,Concert Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/CNCE/news-headlines
178,CNSP,CNS Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/CNSP/news-headlines
179,CNST,Constellation Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/CNST/news-headlines
180,COCP,Cocrystal Pharma Inc.,https://www.nasdaq.com/market-activity/stocks/COCP/news-headlines
181,COGT,Cogent Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/COGT/news-headlines
182,COLL,Collegium Pharmaceutical Inc.,https://www.nasdaq.com/market-activity/stocks/COLL/news-headlines
183,CORT,Corcept Therapeutics Incorporated,https://www.nasdaq.com/market-activity/stocks/CORT/news-headlines
184,CORV,Correvio Pharma Corp.,https://www.nasdaq.com/market-activity/stocks/CORV/news-headlines
185,CPIX,Cumberland Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/CPIX/news-headlines
186,CPRX,Catalyst Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/CPRX/news-headlines
187,CRBP,Corbus Pharmaceuticals Holdings Inc.,https://www.nasdaq.com/market-activity/stocks/CRBP/news-headlines
188,CRDF,Cardiff Oncology Inc.,https://www.nasdaq.com/market-activity/stocks/CRDF/news-headlines
189,CRIS,Curis Inc.,https://www.nasdaq.com/market-activity/stocks/CRIS/news-headlines
190,CRMD,CorMedix Inc.,https://www.nasdaq.com/market-activity/stocks/CRMD/news-headlines
191,CRNX,Crinetics Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/CRNX/news-headlines
192,CRSP,CRISPR Therapeutics AG,https://www.nasdaq.com/market-activity/stocks/CRSP/news-headlines
193,CRTX,Cortexyme Inc.,https://www.nasdaq.com/market-activity/stocks/CRTX/news-headlines
194,CRVS,Corvus Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/CRVS/news-headlines
195,CSII,Cardiovascular Systems Inc.,https://www.nasdaq.com/market-activity/stocks/CSII/news-headlines
196,CTIC,CTI BioPharma Corp.,https://www.nasdaq.com/market-activity/stocks/CTIC/news-headlines
197,CTMX,CytomX Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/CTMX/news-headlines
198,CTXR,Citius Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/CTXR/news-headlines
199,CUE,Cue Biopharma Inc.,https://www.nasdaq.com/market-activity/stocks/CUE/news-headlines
200,CVAC,CureVac N.V.,https://www.nasdaq.com/market-activity/stocks/CVAC/news-headlines
201,CVM,Cel-Sci Corporation,https://www.nasdaq.com/market-activity/stocks/CVM/news-headlines
202,CWBR,CohBar Inc.,https://www.nasdaq.com/market-activity/stocks/CWBR/news-headlines
203,CYAD,Celyad SA,https://www.nasdaq.com/market-activity/stocks/CYAD/news-headlines
204,CYCC,Cyclacel Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/CYCC/news-headlines
205,CYCN,Cyclerion Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/CYCN/news-headlines
206,CYDY,Cytodyn Inc,https://www.nasdaq.com/market-activity/stocks/CYDY/news-headlines
207,CYTK,Cytokinetics Incorporated,https://www.nasdaq.com/market-activity/stocks/CYTK/news-headlines
208,DARE,Dare Bioscience Inc.,https://www.nasdaq.com/market-activity/stocks/DARE/news-headlines
209,DBVT,DBV Technologies S.A.,https://www.nasdaq.com/market-activity/stocks/DBVT/news-headlines
210,DCPH,Deciphera Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/DCPH/news-headlines
211,DCTH,Delcath Systems Inc.,https://www.nasdaq.com/market-activity/stocks/DCTH/news-headlines
212,DFFN,Diffusion Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/DFFN/news-headlines
213,DMAC,DiaMedica Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/DMAC/news-headlines
214,DNLI,Denali Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/DNLI/news-headlines
215,DRMT,Dermavant Sciences Ltd - Ordinary Shares,https://www.nasdaq.com/market-activity/stocks/DRMT/news-headlines
216,DRNA,Dicerna Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/DRNA/news-headlines
217,DRRX,DURECT Corporation,https://www.nasdaq.com/market-activity/stocks/DRRX/news-headlines
218,DTIL,Precision BioSciences Inc.,https://www.nasdaq.com/market-activity/stocks/DTIL/news-headlines
219,DVAX,Dynavax Technologies Corporation,https://www.nasdaq.com/market-activity/stocks/DVAX/news-headlines
220,DYN,Dyne Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/DYN/news-headlines
221,EARS,Auris Medical Holding Ltd.,https://www.nasdaq.com/market-activity/stocks/EARS/news-headlines
222,EBS,Emergent Biosolutions Inc.,https://www.nasdaq.com/market-activity/stocks/EBS/news-headlines
223,EDAP,EDAP TMS S.A.,https://www.nasdaq.com/market-activity/stocks/EDAP/news-headlines
224,EDIT,Editas Medicine Inc.,https://www.nasdaq.com/market-activity/stocks/EDIT/news-headlines
225,EDSA,Edesa Biotech Inc.,https://www.nasdaq.com/market-activity/stocks/EDSA/news-headlines
226,EGRX,Eagle Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/EGRX/news-headlines
227,EIDX,Eidos Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/EIDX/news-headlines
228,EIGR,Eiger BioPharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/EIGR/news-headlines
229,ELOX,Eloxx Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/ELOX/news-headlines
230,ENDP,Endo International plc,https://www.nasdaq.com/market-activity/stocks/ENDP/news-headlines
231,ENLV,Enlivex Therapeutics Ltd.,https://www.nasdaq.com/market-activity/stocks/ENLV/news-headlines
232,ENTA,Enanta Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/ENTA/news-headlines
233,ENTX,Entera Bio Ltd.,https://www.nasdaq.com/market-activity/stocks/ENTX/news-headlines
234,EOLS,Evolus Inc.,https://www.nasdaq.com/market-activity/stocks/EOLS/news-headlines
235,EPIX,ESSA Pharma Inc.,https://www.nasdaq.com/market-activity/stocks/EPIX/news-headlines
236,EPZM,Epizyme Inc.,https://www.nasdaq.com/market-activity/stocks/EPZM/news-headlines
237,EQ,Equillium Inc.,https://www.nasdaq.com/market-activity/stocks/EQ/news-headlines
238,ERYP,Erytech Pharma S.A.,https://www.nasdaq.com/market-activity/stocks/ERYP/news-headlines
239,ESPR,Esperion Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/ESPR/news-headlines
240,ETNB,89bio Inc.,https://www.nasdaq.com/market-activity/stocks/ETNB/news-headlines
241,ETON,Eton Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/ETON/news-headlines
242,ETTX,Entasis Therapeutics Holdings Inc.,https://www.nasdaq.com/market-activity/stocks/ETTX/news-headlines
243,EVFM,Evofem Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/EVFM/news-headlines
244,EVLO,Evelo Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/EVLO/news-headlines
245,EVOK,Evoke Pharma Inc.,https://www.nasdaq.com/market-activity/stocks/EVOK/news-headlines
246,EXAS,Exact Sciences Corporation,https://www.nasdaq.com/market-activity/stocks/EXAS/news-headlines
247,EXEL,Exelixis Inc.,https://www.nasdaq.com/market-activity/stocks/EXEL/news-headlines
248,EYEG,Eyegate Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/EYEG/news-headlines
249,EYEN,Eyenovia Inc.,https://www.nasdaq.com/market-activity/stocks/EYEN/news-headlines
250,EYPT,EyePoint Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/EYPT/news-headlines
251,FATE,Fate Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/FATE/news-headlines
252,FBIO,Fortress Biotech Inc.,https://www.nasdaq.com/market-activity/stocks/FBIO/news-headlines
253,FENC,Fennec Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/FENC/news-headlines
254,FGEN,FibroGen Inc,https://www.nasdaq.com/market-activity/stocks/FGEN/news-headlines
255,FIXX,Homology Medicines Inc.,https://www.nasdaq.com/market-activity/stocks/FIXX/news-headlines
256,FLXN,Flexion Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/FLXN/news-headlines
257,FMTX,Forma Therapeutics Holdings Inc.,https://www.nasdaq.com/market-activity/stocks/FMTX/news-headlines
258,FOLD,Amicus Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/FOLD/news-headlines
259,FPRX,Five Prime Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/FPRX/news-headlines
260,FREQ,Frequency Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/FREQ/news-headlines
261,FRLN,Freeline Therapeutics Holdings plc,https://www.nasdaq.com/market-activity/stocks/FRLN/news-headlines
262,FULC,Fulcrum Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/FULC/news-headlines
263,FUSN,Fusion Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/FUSN/news-headlines
264,FWP,Forward Pharma A/S,https://www.nasdaq.com/market-activity/stocks/FWP/news-headlines
265,GALT,Galectin Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/GALT/news-headlines
266,GBIO,Generation Bio Co.,https://www.nasdaq.com/market-activity/stocks/GBIO/news-headlines
267,GBT,Global Blood Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/GBT/news-headlines
268,GERN,Geron Corporation,https://www.nasdaq.com/market-activity/stocks/GERN/news-headlines
269,GILD,Gilead Sciences Inc.,https://www.nasdaq.com/market-activity/stocks/GILD/news-headlines
270,GKOS,Glaukos Corporation,https://www.nasdaq.com/market-activity/stocks/GKOS/news-headlines
271,GLMD,Galmed Pharmaceuticals Ltd.,https://www.nasdaq.com/market-activity/stocks/GLMD/news-headlines
272,GLPG,Galapagos NV,https://www.nasdaq.com/market-activity/stocks/GLPG/news-headlines
273,GLYC,GlycoMimetics Inc.,https://www.nasdaq.com/market-activity/stocks/GLYC/news-headlines
274,GMAB,Genmab A/S,https://www.nasdaq.com/market-activity/stocks/GMAB/news-headlines
275,GMDA,Gamida Cell Ltd.,https://www.nasdaq.com/market-activity/stocks/GMDA/news-headlines
276,GNCA,Genocea Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/GNCA/news-headlines
277,GNFT,GENFIT S.A.,https://www.nasdaq.com/market-activity/stocks/GNFT/news-headlines
278,GNPX,Genprex Inc.,https://www.nasdaq.com/market-activity/stocks/GNPX/news-headlines
279,GOSS,Gossamer Bio Inc.,https://www.nasdaq.com/market-activity/stocks/GOSS/news-headlines
280,GRTS,Gritstone Oncology Inc.,https://www.nasdaq.com/market-activity/stocks/GRTS/news-headlines
281,GRTX,Galera Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/GRTX/news-headlines
282,GSK,GlaxoSmithKline PLC,https://www.nasdaq.com/market-activity/stocks/GSK/news-headlines
283,GTHX,G1 Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/GTHX/news-headlines
284,GWPH,GW Pharmaceuticals Plc,https://www.nasdaq.com/market-activity/stocks/GWPH/news-headlines
285,HALO,Halozyme Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/HALO/news-headlines
286,HARP,Harpoon Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/HARP/news-headlines
287,HCM,Hutchison China MediTech Limited,https://www.nasdaq.com/market-activity/stocks/HCM/news-headlines
288,HEPA,Hepion Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/HEPA/news-headlines
289,HOOK,HOOKIPA Pharma Inc.,https://www.nasdaq.com/market-activity/stocks/HOOK/news-headlines
290,HOTH,Hoth Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/HOTH/news-headlines
291,HRMY,Harmony Biosciences Holdings Inc.,https://www.nasdaq.com/market-activity/stocks/HRMY/news-headlines
292,HRTX,Heron Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/HRTX/news-headlines
293,HSTO,Histogen Inc.,https://www.nasdaq.com/market-activity/stocks/HSTO/news-headlines
294,HTBX,Heat Biologics Inc.,https://www.nasdaq.com/market-activity/stocks/HTBX/news-headlines
295,HZNP,Horizon Therapeutics Public Limited Company,https://www.nasdaq.com/market-activity/stocks/HZNP/news-headlines
296,IBIO,iBio Inc.,https://www.nasdaq.com/market-activity/stocks/IBIO/news-headlines
297,ICPT,Intercept Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/ICPT/news-headlines
298,IDRA,Idera Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/IDRA/news-headlines
299,IDYA,IDEAYA Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/IDYA/news-headlines
300,IFRX,InflaRx N.V.,https://www.nasdaq.com/market-activity/stocks/IFRX/news-headlines
301,IGMS,IGM Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/IGMS/news-headlines
302,IGXT,IntelGenx Technologies Corp,https://www.nasdaq.com/market-activity/stocks/IGXT/news-headlines
303,IMAB,I-Mab,https://www.nasdaq.com/market-activity/stocks/IMAB/news-headlines
304,IMGN,ImmunoGen Inc.,https://www.nasdaq.com/market-activity/stocks/IMGN/news-headlines
305,IMMP,Immutep Limited,https://www.nasdaq.com/market-activity/stocks/IMMP/news-headlines
306,IMMU,Immunomedics Inc.,https://www.nasdaq.com/market-activity/stocks/IMMU/news-headlines
307,IMNM,Immunome Inc.,https://www.nasdaq.com/market-activity/stocks/IMNM/news-headlines
308,IMRA,IMARA Inc.,https://www.nasdaq.com/market-activity/stocks/IMRA/news-headlines
309,IMRN,Immuron Limited,https://www.nasdaq.com/market-activity/stocks/IMRN/news-headlines
310,IMUX,Immunic Inc.,https://www.nasdaq.com/market-activity/stocks/IMUX/news-headlines
311,IMV,IMV Inc.,https://www.nasdaq.com/market-activity/stocks/IMV/news-headlines
312,IMVT,Immunovant Inc.,https://www.nasdaq.com/market-activity/stocks/IMVT/news-headlines
313,INBX,Inhibrx Inc.,https://www.nasdaq.com/market-activity/stocks/INBX/news-headlines
314,INCY,Incyte Corporation,https://www.nasdaq.com/market-activity/stocks/INCY/news-headlines
315,INFI,Infinity Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/INFI/news-headlines
316,INMB,INmune Bio Inc.,https://www.nasdaq.com/market-activity/stocks/INMB/news-headlines
318,INO,Inovio Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/INO/news-headlines
319,INSM,Insmed Inc.,https://www.nasdaq.com/market-activity/stocks/INSM/news-headlines
320,INVA,Innoviva Inc.,https://www.nasdaq.com/market-activity/stocks/INVA/news-headlines
321,INZY,Inozyme Pharma Inc.,https://www.nasdaq.com/market-activity/stocks/INZY/news-headlines
322,IONS,Ionis Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/IONS/news-headlines
323,IOVA,Iovance Biotherapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/IOVA/news-headlines
324,IPHA,Innate Pharma S.A.,https://www.nasdaq.com/market-activity/stocks/IPHA/news-headlines
325,IRWD,Ironwood Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/IRWD/news-headlines
326,ISEE,IVERIC bio Inc.,https://www.nasdaq.com/market-activity/stocks/ISEE/news-headlines
327,ITCI,Intra-Cellular Therapies Inc.,https://www.nasdaq.com/market-activity/stocks/ITCI/news-headlines
328,ITOS,iTeos Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/ITOS/news-headlines
329,ITRM,Iterum Therapeutics plc,https://www.nasdaq.com/market-activity/stocks/ITRM/news-headlines
330,IVA,Inventiva S.A.,https://www.nasdaq.com/market-activity/stocks/IVA/news-headlines
331,JAGX,Jaguar Health Inc.,https://www.nasdaq.com/market-activity/stocks/JAGX/news-headlines
332,JAZZ,Jazz Pharmaceuticals plc,https://www.nasdaq.com/market-activity/stocks/JAZZ/news-headlines
333,JNCE,Jounce Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/JNCE/news-headlines
334,JNJ,Johnson & Johnson,https://www.nasdaq.com/market-activity/stocks/JNJ/news-headlines
335,KALA,Kala Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/KALA/news-headlines
336,KALV,KalVista Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/KALV/news-headlines
337,KDMN,Kadmon Holdings Inc.,https://www.nasdaq.com/market-activity/stocks/KDMN/news-headlines
338,KDNY,Chinook Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/KDNY/news-headlines
339,KLDO,Kaleido Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/KLDO/news-headlines
340,KMDA,Kamada Ltd.,https://www.nasdaq.com/market-activity/stocks/KMDA/news-headlines
341,KMPH,KemPharm Inc,https://www.nasdaq.com/market-activity/stocks/KMPH/news-headlines
342,KNSA,Kiniksa Pharmaceuticals Ltd.,https://www.nasdaq.com/market-activity/stocks/KNSA/news-headlines
343,KOD,Kodiak Sciences Inc,https://www.nasdaq.com/market-activity/stocks/KOD/news-headlines
344,KPTI,Karyopharm Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/KPTI/news-headlines
345,KRBP,,https://www.nasdaq.com/market-activity/stocks/KRBP/news-headlines
346,KRON,Kronos Bio Inc.,https://www.nasdaq.com/market-activity/stocks/KRON/news-headlines
347,KROS,Keros Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/KROS/news-headlines
348,KRTX,Karuna Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/KRTX/news-headlines
349,KRYS,Krystal Biotech Inc.,https://www.nasdaq.com/market-activity/stocks/KRYS/news-headlines
350,KTOV,Kitov Pharma Ltd.,https://www.nasdaq.com/market-activity/stocks/KTOV/news-headlines
351,KTRA,Kintara Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/KTRA/news-headlines
352,KURA,Kura Oncology Inc.,https://www.nasdaq.com/market-activity/stocks/KURA/news-headlines
353,KYMR,Kymera Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/KYMR/news-headlines
354,KZIA,Kazia Therapeutics Limited,https://www.nasdaq.com/market-activity/stocks/KZIA/news-headlines
355,KZR,Kezar Life Sciences Inc.,https://www.nasdaq.com/market-activity/stocks/KZR/news-headlines
356,LCTX,"Lineage Cell Therapeutics, Inc.",https://www.nasdaq.com/market-activity/stocks/LCTX/news-headlines
357,LEGN,Legend Biotech Corporation,https://www.nasdaq.com/market-activity/stocks/LEGN/news-headlines
358,LGND,Ligand Pharmaceuticals Incorporated,https://www.nasdaq.com/market-activity/stocks/LGND/news-headlines
359,LIFE,aTyr Pharma Inc.,https://www.nasdaq.com/market-activity/stocks/LIFE/news-headlines
360,LJPC,La Jolla Pharmaceutical Company,https://www.nasdaq.com/market-activity/stocks/LJPC/news-headlines
361,LLY,Eli Lilly and Company,https://www.nasdaq.com/market-activity/stocks/LLY/news-headlines
362,LNTH,Lantheus Holdings Inc.,https://www.nasdaq.com/market-activity/stocks/LNTH/news-headlines
363,LOGC,LogicBio Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/LOGC/news-headlines
364,LPCN,Lipocine Inc.,https://www.nasdaq.com/market-activity/stocks/LPCN/news-headlines
365,LPTX,Leap Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/LPTX/news-headlines
366,LQDA,Liquidia Technologies Inc.,https://www.nasdaq.com/market-activity/stocks/LQDA/news-headlines
367,LRMR,Larimar Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/LRMR/news-headlines
368,LUMO,Lumos Pharma Inc.,https://www.nasdaq.com/market-activity/stocks/LUMO/news-headlines
369,LXRX,Lexicon Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/LXRX/news-headlines
370,LYRA,Lyra Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/LYRA/news-headlines
371,MACK,Merrimack Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/MACK/news-headlines
372,MBIO,Mustang Bio Inc.,https://www.nasdaq.com/market-activity/stocks/MBIO/news-headlines
373,MBRX,Moleculin Biotech Inc.,https://www.nasdaq.com/market-activity/stocks/MBRX/news-headlines
374,MCRB,Seres Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/MCRB/news-headlines
375,MDGL,Madrigal Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/MDGL/news-headlines
376,MDWD,MediWound Ltd.,https://www.nasdaq.com/market-activity/stocks/MDWD/news-headlines
377,MEIP,MEI Pharma Inc.,https://www.nasdaq.com/market-activity/stocks/MEIP/news-headlines
378,MESO,Mesoblast Limited,https://www.nasdaq.com/market-activity/stocks/MESO/news-headlines
379,MGEN,Miragen Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/MGEN/news-headlines
380,MGNX,MacroGenics Inc.,https://www.nasdaq.com/market-activity/stocks/MGNX/news-headlines
381,MGTA,Magenta Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/MGTA/news-headlines
382,MGTX,MeiraGTx Holdings plc,https://www.nasdaq.com/market-activity/stocks/MGTX/news-headlines
383,MIRM,Mirum Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/MIRM/news-headlines
384,MIST,Milestone Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/MIST/news-headlines
385,MITO,Stealth BioTherapeutics Corp.,https://www.nasdaq.com/market-activity/stocks/MITO/news-headlines
386,MLND,Millendo Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/MLND/news-headlines
387,MNK,Mallinckrodt plc,https://www.nasdaq.com/market-activity/stocks/MNK/news-headlines
388,MNKD,MannKind Corporation,https://www.nasdaq.com/market-activity/stocks/MNKD/news-headlines
389,MNLO,VYNE Therapeutics,https://www.nasdaq.com/market-activity/stocks/MNLO/news-headlines
390,MNOV,MediciNova Inc.,https://www.nasdaq.com/market-activity/stocks/MNOV/news-headlines
391,MNPR,Monopar Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/MNPR/news-headlines
392,MOR,MorphoSys AG,https://www.nasdaq.com/market-activity/stocks/MOR/news-headlines
393,MORF,Morphic Holding Inc.,https://www.nasdaq.com/market-activity/stocks/MORF/news-headlines
394,MREO,Mereo BioPharma Group plc,https://www.nasdaq.com/market-activity/stocks/MREO/news-headlines
395,MRK,Merck & Company Inc. (new),https://www.nasdaq.com/market-activity/stocks/MRK/news-headlines
396,MRKR,Marker Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/MRKR/news-headlines
397,MRNA,Moderna Inc.,https://www.nasdaq.com/market-activity/stocks/MRNA/news-headlines
398,MRNS,Marinus Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/MRNS/news-headlines
399,MRSN,Mersana Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/MRSN/news-headlines
400,MRTX,Mirati Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/MRTX/news-headlines
401,MRUS,Merus N.V.,https://www.nasdaq.com/market-activity/stocks/MRUS/news-headlines
402,MTCR,Metacrine Inc.,https://www.nasdaq.com/market-activity/stocks/MTCR/news-headlines
403,MTEM,Molecular Templates Inc.,https://www.nasdaq.com/market-activity/stocks/MTEM/news-headlines
404,MTNB,Matinas Biopharma Holdings Inc.,https://www.nasdaq.com/market-activity/stocks/MTNB/news-headlines
405,MYL,Mylan N.V.,https://www.nasdaq.com/market-activity/stocks/MYL/news-headlines
406,MYOK,MyoKardia Inc.,https://www.nasdaq.com/market-activity/stocks/MYOK/news-headlines
407,MYOV,Myovant Sciences Ltd.,https://www.nasdaq.com/market-activity/stocks/MYOV/news-headlines
408,NAVB,Navidea Biopharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/NAVB/news-headlines
409,NBIX,Neurocrine Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/NBIX/news-headlines
410,NBRV,Nabriva Therapeutics plc,https://www.nasdaq.com/market-activity/stocks/NBRV/news-headlines
411,NBY,NovaBay Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/NBY/news-headlines
412,NCNA,NuCana plc,https://www.nasdaq.com/market-activity/stocks/NCNA/news-headlines
413,NEOS,Neos Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/NEOS/news-headlines
414,NERV,Minerva Neurosciences Inc,https://www.nasdaq.com/market-activity/stocks/NERV/news-headlines
415,NGM,NGM Biopharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/NGM/news-headlines
416,NK,NantKwest Inc.,https://www.nasdaq.com/market-activity/stocks/NK/news-headlines
417,NKTR,Nektar Therapeutics,https://www.nasdaq.com/market-activity/stocks/NKTR/news-headlines
418,NKTX,Nkarta Inc.,https://www.nasdaq.com/market-activity/stocks/NKTX/news-headlines
419,NLTX,Neoleukin Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/NLTX/news-headlines
420,NMTR,9 Meters Biopharma Inc.,https://www.nasdaq.com/market-activity/stocks/NMTR/news-headlines
421,NNVC,NanoViricides Inc.,https://www.nasdaq.com/market-activity/stocks/NNVC/news-headlines
422,NOVN,Novan Inc.,https://www.nasdaq.com/market-activity/stocks/NOVN/news-headlines
423,NRBO,NeuroBo Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/NRBO/news-headlines
424,NRIX,Nurix Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/NRIX/news-headlines
425,NTEC,Intec Pharma Ltd.,https://www.nasdaq.com/market-activity/stocks/NTEC/news-headlines
426,NTLA,Intellia Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/NTLA/news-headlines
427,NTRP,Neurotrope Inc.,https://www.nasdaq.com/market-activity/stocks/NTRP/news-headlines
428,NVAX,Novavax Inc.,https://www.nasdaq.com/market-activity/stocks/NVAX/news-headlines
429,NVCR,NovoCure Limited,https://www.nasdaq.com/market-activity/stocks/NVCR/news-headlines
430,NVIV,InVivo Therapeutics Holdings Corp.,https://www.nasdaq.com/market-activity/stocks/NVIV/news-headlines
431,NVO,Novo Nordisk A/S,https://www.nasdaq.com/market-activity/stocks/NVO/news-headlines
432,NVS,Novartis AG,https://www.nasdaq.com/market-activity/stocks/NVS/news-headlines
433,NVUS,Novus Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/NVUS/news-headlines
434,NWRN,,https://www.nasdaq.com/market-activity/stocks/NWRN/news-headlines
435,NXTC,NextCure Inc.,https://www.nasdaq.com/market-activity/stocks/NXTC/news-headlines
436,NYMX,Nymox Pharmaceutical Corporation,https://www.nasdaq.com/market-activity/stocks/NYMX/news-headlines
437,OBSV,ObsEva SA,https://www.nasdaq.com/market-activity/stocks/OBSV/news-headlines
438,OCGN,"Ocugen, Inc.",https://www.nasdaq.com/market-activity/stocks/OCGN/news-headlines
439,OCUL,Ocular Therapeutix Inc.,https://www.nasdaq.com/market-activity/stocks/OCUL/news-headlines
440,ODT,Odonate Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/ODT/news-headlines
441,OGEN,Oragenics Inc.,https://www.nasdaq.com/market-activity/stocks/OGEN/news-headlines
442,OMER,Omeros Corporation,https://www.nasdaq.com/market-activity/stocks/OMER/news-headlines
443,ONCR,Oncorus Inc.,https://www.nasdaq.com/market-activity/stocks/ONCR/news-headlines
444,ONCS,OncoSec Medical Incorporated,https://www.nasdaq.com/market-activity/stocks/ONCS/news-headlines
445,ONCT,Oncternal Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/ONCT/news-headlines
446,ONCY,Oncolytics Biotech Inc.,https://www.nasdaq.com/market-activity/stocks/ONCY/news-headlines
447,ONTX,Onconova Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/ONTX/news-headlines
448,OPK,Opko Health Inc.,https://www.nasdaq.com/market-activity/stocks/OPK/news-headlines
449,OPNT,Opiant Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/OPNT/news-headlines
450,OPTN,OptiNose Inc.,https://www.nasdaq.com/market-activity/stocks/OPTN/news-headlines
451,ORIC,Oric Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/ORIC/news-headlines
452,ORMP,Oramed Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/ORMP/news-headlines
453,ORTX,Orchard Therapeutics plc,https://www.nasdaq.com/market-activity/stocks/ORTX/news-headlines
454,OSMT,Osmotica Pharmaceuticals plc,https://www.nasdaq.com/market-activity/stocks/OSMT/news-headlines
455,OTIC,Otonomy Inc.,https://www.nasdaq.com/market-activity/stocks/OTIC/news-headlines
456,OTLK,Outlook Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/OTLK/news-headlines
457,OVID,Ovid Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/OVID/news-headlines
458,OYST,Oyster Point Pharma Inc.,https://www.nasdaq.com/market-activity/stocks/OYST/news-headlines
459,PASG,Passage Bio Inc.,https://www.nasdaq.com/market-activity/stocks/PASG/news-headlines
460,PBYI,Puma Biotechnology Inc,https://www.nasdaq.com/market-activity/stocks/PBYI/news-headlines
461,PCRX,Pacira BioSciences Inc.,https://www.nasdaq.com/market-activity/stocks/PCRX/news-headlines
462,PCVX,Vaxcyte Inc.,https://www.nasdaq.com/market-activity/stocks/PCVX/news-headlines
463,PDSB,PDS Biotechnology Corporation,https://www.nasdaq.com/market-activity/stocks/PDSB/news-headlines
464,PFE,Pfizer Inc.,https://www.nasdaq.com/market-activity/stocks/PFE/news-headlines
465,PFRX,,https://www.nasdaq.com/market-activity/stocks/PFRX/news-headlines
466,PGEN,Precigen Inc.,https://www.nasdaq.com/market-activity/stocks/PGEN/news-headlines
467,PHAS,PhaseBio Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/PHAS/news-headlines
468,PHAT,Phathom Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/PHAT/news-headlines
469,PHIO,Phio Pharmaceuticals Corp.,https://www.nasdaq.com/market-activity/stocks/PHIO/news-headlines
470,PIRS,Pieris Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/PIRS/news-headlines
471,PLRX,Pliant Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/PLRX/news-headlines
472,PLUS,ePlus inc.,https://www.nasdaq.com/market-activity/stocks/PLUS/news-headlines
473,PLX,Protalix BioTherapeutics Inc. (DE),https://www.nasdaq.com/market-activity/stocks/PLX/news-headlines
474,PLXP,PLx Pharma Inc.,https://www.nasdaq.com/market-activity/stocks/PLXP/news-headlines
475,PNSL,,https://www.nasdaq.com/market-activity/stocks/PNSL/news-headlines
476,PRAX,,https://www.nasdaq.com/market-activity/stocks/PRAX/news-headlines
477,PROG,Progenity Inc.,https://www.nasdaq.com/market-activity/stocks/PROG/news-headlines
478,PRQR,ProQR Therapeutics N.V.,https://www.nasdaq.com/market-activity/stocks/PRQR/news-headlines
479,PRTA,Prothena Corporation plc,https://www.nasdaq.com/market-activity/stocks/PRTA/news-headlines
480,PRTK,Paratek Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/PRTK/news-headlines
481,PRVB,Provention Bio Inc.,https://www.nasdaq.com/market-activity/stocks/PRVB/news-headlines
482,PRVL,Prevail Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/PRVL/news-headlines
483,PSNL,Personalis Inc.,https://www.nasdaq.com/market-activity/stocks/PSNL/news-headlines
484,PSTI,Pluristem Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/PSTI/news-headlines
485,PSTV,PLUS THERAPEUTICS Inc.,https://www.nasdaq.com/market-activity/stocks/PSTV/news-headlines
486,PSTX,Poseida Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/PSTX/news-headlines
487,PTCT,PTC Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/PTCT/news-headlines
488,PTGX,Protagonist Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/PTGX/news-headlines
489,PTI,Proteostasis Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/PTI/news-headlines
490,PTN,Palatin Technologies Inc.,https://www.nasdaq.com/market-activity/stocks/PTN/news-headlines
491,PULM,Pulmatrix Inc.,https://www.nasdaq.com/market-activity/stocks/PULM/news-headlines
492,PYPD,PolyPid Ltd.,https://www.nasdaq.com/market-activity/stocks/PYPD/news-headlines
493,QLGN,Qualigen Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/QLGN/news-headlines
494,QURE,uniQure N.V.,https://www.nasdaq.com/market-activity/stocks/QURE/news-headlines
495,RAPT,RAPT Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/RAPT/news-headlines
496,RARE,Ultragenyx Pharmaceutical Inc.,https://www.nasdaq.com/market-activity/stocks/RARE/news-headlines
497,RCKT,Rocket Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/RCKT/news-headlines
498,RCUS,Arcus Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/RCUS/news-headlines
499,RDHL,Redhill Biopharma Ltd.,https://www.nasdaq.com/market-activity/stocks/RDHL/news-headlines
500,RDUS,Radius Health Inc.,https://www.nasdaq.com/market-activity/stocks/RDUS/news-headlines
501,REGN,Regeneron Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/REGN/news-headlines
502,REPH,Recro Pharma Inc.,https://www.nasdaq.com/market-activity/stocks/REPH/news-headlines
503,REPL,Replimune Group Inc.,https://www.nasdaq.com/market-activity/stocks/REPL/news-headlines
504,RETA,Reata Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/RETA/news-headlines
505,REXN,Rexahn Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/REXN/news-headlines
506,RGEN,Repligen Corporation,https://www.nasdaq.com/market-activity/stocks/RGEN/news-headlines
507,RGLS,Regulus Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/RGLS/news-headlines
508,RGNX,REGENXBIO Inc.,https://www.nasdaq.com/market-activity/stocks/RGNX/news-headlines
509,RHHBY,Roche Holding AG ADR,https://www.nasdaq.com/market-activity/stocks/RHHBY/news-headlines
510,RIGL,Rigel Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/RIGL/news-headlines
511,RLAY,Relay Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/RLAY/news-headlines
512,RLMD,Relmada Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/RLMD/news-headlines
513,RMTI,Rockwell Medical Inc.,https://www.nasdaq.com/market-activity/stocks/RMTI/news-headlines
514,RNA,Avidity Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/RNA/news-headlines
515,RNLX,Renalytix AI plc,https://www.nasdaq.com/market-activity/stocks/RNLX/news-headlines
516,RPTX,Repare Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/RPTX/news-headlines
517,RTRX,Retrophin Inc.,https://www.nasdaq.com/market-activity/stocks/RTRX/news-headlines
518,RUBY,Rubius Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/RUBY/news-headlines
519,RVMD,Revolution Medicines Inc - Ordinary Shares,https://www.nasdaq.com/market-activity/stocks/RVMD/news-headlines
520,RVNC,Revance Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/RVNC/news-headlines
521,RVVTF,Revive Therapeutics Ltd,https://www.nasdaq.com/market-activity/stocks/RVVTF/news-headlines
522,RYTM,Rhythm Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/RYTM/news-headlines
523,SAGE,Sage Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/SAGE/news-headlines
524,SAVA,Cassava Sciences Inc.,https://www.nasdaq.com/market-activity/stocks/SAVA/news-headlines
525,SBBP,Strongbridge Biopharma plc,https://www.nasdaq.com/market-activity/stocks/SBBP/news-headlines
526,SBPH,Spring Bank Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/SBPH/news-headlines
527,SCPH,scPharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/SCPH/news-headlines
528,SCYX,SCYNEXIS Inc.,https://www.nasdaq.com/market-activity/stocks/SCYX/news-headlines
529,SEEL,Seelos Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/SEEL/news-headlines
530,SELB,Selecta Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/SELB/news-headlines
531,SESN,Sesen Bio Inc.,https://www.nasdaq.com/market-activity/stocks/SESN/news-headlines
532,SGEN,Seagen Inc Com,https://www.nasdaq.com/market-activity/stocks/SGEN/news-headlines
533,SGMO,Sangamo Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/SGMO/news-headlines
534,SIGA,SIGA Technologies Inc.,https://www.nasdaq.com/market-activity/stocks/SIGA/news-headlines
535,SLDB,Solid Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/SLDB/news-headlines
536,SLGL,Sol-Gel Technologies Ltd.,https://www.nasdaq.com/market-activity/stocks/SLGL/news-headlines
537,SLNO,Soleno Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/SLNO/news-headlines
538,SLRX,Salarius Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/SLRX/news-headlines
539,SLS,SELLAS Life Sciences Group Inc.,https://www.nasdaq.com/market-activity/stocks/SLS/news-headlines
540,SMMT,Summit Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/SMMT/news-headlines
541,SNCA,Seneca Biopharma Inc.,https://www.nasdaq.com/market-activity/stocks/SNCA/news-headlines
542,SNDX,Syndax Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/SNDX/news-headlines
543,SNGX,Soligenix Inc.,https://www.nasdaq.com/market-activity/stocks/SNGX/news-headlines
544,SNSS,Sunesis Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/SNSS/news-headlines
545,SNY,Sanofi,https://www.nasdaq.com/market-activity/stocks/SNY/news-headlines
546,SONN,Sonnet BioTherapeutics Holdings Inc.,https://www.nasdaq.com/market-activity/stocks/SONN/news-headlines
547,SPPI,Spectrum Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/SPPI/news-headlines
548,SPRB,Spruce Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/SPRB/news-headlines
549,SPRO,Spero Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/SPRO/news-headlines
550,SRNE,Sorrento Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/SRNE/news-headlines
551,SRPT,Sarepta Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/SRPT/news-headlines
552,SRRA,Sierra Oncology Inc.,https://www.nasdaq.com/market-activity/stocks/SRRA/news-headlines
553,SRRK,Scholar Rock Holding Corporation,https://www.nasdaq.com/market-activity/stocks/SRRK/news-headlines
554,STOK,Stoke Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/STOK/news-headlines
555,STRO,Sutro Biopharma Inc.,https://www.nasdaq.com/market-activity/stocks/STRO/news-headlines
556,STSA,Satsuma Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/STSA/news-headlines
557,STTK,Shattuck Labs Inc.,https://www.nasdaq.com/market-activity/stocks/STTK/news-headlines
558,SUPN,Supernus Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/SUPN/news-headlines
559,SURF,Surface Oncology Inc.,https://www.nasdaq.com/market-activity/stocks/SURF/news-headlines
560,SVA,Sinovac Biotech Ltd.,https://www.nasdaq.com/market-activity/stocks/SVA/news-headlines
561,SVRA,Savara Inc.,https://www.nasdaq.com/market-activity/stocks/SVRA/news-headlines
562,SWTX,SpringWorks Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/SWTX/news-headlines
563,SYBX,Synlogic Inc.,https://www.nasdaq.com/market-activity/stocks/SYBX/news-headlines
564,SYN,Synthetic Biologics Inc.,https://www.nasdaq.com/market-activity/stocks/SYN/news-headlines
565,SYRS,Syros Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/SYRS/news-headlines
566,TAK,Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of),https://www.nasdaq.com/market-activity/stocks/TAK/news-headlines
567,TARA,Protara Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/TARA/news-headlines
568,TBIO,Translate Bio Inc.,https://www.nasdaq.com/market-activity/stocks/TBIO/news-headlines
569,TBPH,Theravance Biopharma Inc.,https://www.nasdaq.com/market-activity/stocks/TBPH/news-headlines
570,TCDA,Tricida Inc.,https://www.nasdaq.com/market-activity/stocks/TCDA/news-headlines
571,TCON,TRACON Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/TCON/news-headlines
572,TCRR,TCR2 Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/TCRR/news-headlines
573,TENX,Tenax Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/TENX/news-headlines
574,TEVA,Teva Pharmaceutical Industries Limited American Depositary Shares,https://www.nasdaq.com/market-activity/stocks/TEVA/news-headlines
575,TFFP,TFF Pharmaceuticals Inc - Ordinary Shares,https://www.nasdaq.com/market-activity/stocks/TFFP/news-headlines
576,TGTX,TG Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/TGTX/news-headlines
577,TLC,Taiwan Liposome Company Ltd.,https://www.nasdaq.com/market-activity/stocks/TLC/news-headlines
578,TLSA,Tiziana Life Sciences plc,https://www.nasdaq.com/market-activity/stocks/TLSA/news-headlines
579,TMBR,Timber Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/TMBR/news-headlines
580,TNXP,Tonix Pharmaceuticals Holding Corp.,https://www.nasdaq.com/market-activity/stocks/TNXP/news-headlines
581,TOCA,Tocagen,https://www.nasdaq.com/market-activity/stocks/TOCA/news-headlines
582,TPTX,Turning Point Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/TPTX/news-headlines
583,TRIL,Trillium Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/TRIL/news-headlines
584,TRVI,Trevi Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/TRVI/news-headlines
585,TRVN,Trevena Inc.,https://www.nasdaq.com/market-activity/stocks/TRVN/news-headlines
586,TTNP,Titan Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/TTNP/news-headlines
587,TXMD,TherapeuticsMD Inc.,https://www.nasdaq.com/market-activity/stocks/TXMD/news-headlines
588,TYME,Tyme Technologies Inc.,https://www.nasdaq.com/market-activity/stocks/TYME/news-headlines
589,UBX,Unity Biotechnology Inc.,https://www.nasdaq.com/market-activity/stocks/UBX/news-headlines
590,URGN,UroGen Pharma Ltd.,https://www.nasdaq.com/market-activity/stocks/URGN/news-headlines
591,UROV,Urovant Sciences Ltd.,https://www.nasdaq.com/market-activity/stocks/UROV/news-headlines
592,UTHR,United Therapeutics Corporation,https://www.nasdaq.com/market-activity/stocks/UTHR/news-headlines
593,VBIV,VBI Vaccines Inc.,https://www.nasdaq.com/market-activity/stocks/VBIV/news-headlines
594,VBLT,Vascular Biogenics Ltd.,https://www.nasdaq.com/market-activity/stocks/VBLT/news-headlines
595,VCEL,Vericel Corporation,https://www.nasdaq.com/market-activity/stocks/VCEL/news-headlines
596,VCNX,Vaccinex Inc.,https://www.nasdaq.com/market-activity/stocks/VCNX/news-headlines
597,VERU,Veru Inc.,https://www.nasdaq.com/market-activity/stocks/VERU/news-headlines
598,VIE,Viela Bio Inc.,https://www.nasdaq.com/market-activity/stocks/VIE/news-headlines
599,VIR,Vir Biotechnology Inc.,https://www.nasdaq.com/market-activity/stocks/VIR/news-headlines
600,VKTX,Viking Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/VKTX/news-headlines
601,VNDA,Vanda Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/VNDA/news-headlines
602,VRCA,Verrica Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/VRCA/news-headlines
603,VRNA,Verona Pharma plc,https://www.nasdaq.com/market-activity/stocks/VRNA/news-headlines
604,VRTX,Vertex Pharmaceuticals Incorporated,https://www.nasdaq.com/market-activity/stocks/VRTX/news-headlines
605,VSTM,Verastem Inc.,https://www.nasdaq.com/market-activity/stocks/VSTM/news-headlines
606,VTGN,VistaGen Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/VTGN/news-headlines
607,VTVT,vTv Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/VTVT/news-headlines
608,VVUS,,https://www.nasdaq.com/market-activity/stocks/VVUS/news-headlines
609,VXRT,Vaxart Inc.,https://www.nasdaq.com/market-activity/stocks/VXRT/news-headlines
610,VYGR,Voyager Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/VYGR/news-headlines
611,WVE,Wave Life Sciences Ltd.,https://www.nasdaq.com/market-activity/stocks/WVE/news-headlines
612,XBIO,Xenetic Biosciences Inc.,https://www.nasdaq.com/market-activity/stocks/XBIO/news-headlines
613,XBIT,XBiotech Inc.,https://www.nasdaq.com/market-activity/stocks/XBIT/news-headlines
614,XENE,Xenon Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/XENE/news-headlines
615,XENT,Intersect ENT Inc.,https://www.nasdaq.com/market-activity/stocks/XENT/news-headlines
616,XERS,Xeris Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/XERS/news-headlines
617,XFOR,X4 Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/XFOR/news-headlines
618,XLRN,Acceleron Pharma Inc.,https://www.nasdaq.com/market-activity/stocks/XLRN/news-headlines
619,XNCR,Xencor Inc.,https://www.nasdaq.com/market-activity/stocks/XNCR/news-headlines
620,XOMA,XOMA Corporation,https://www.nasdaq.com/market-activity/stocks/XOMA/news-headlines
621,XTLB,XTL Biopharmaceuticals Ltd.,https://www.nasdaq.com/market-activity/stocks/XTLB/news-headlines
622,XXII,22nd Century Group Inc.,https://www.nasdaq.com/market-activity/stocks/XXII/news-headlines
623,YMAB,Y-mAbs Therapeutics Inc.,https://www.nasdaq.com/market-activity/stocks/YMAB/news-headlines
624,ZEAL,Zealand Pharma A/S,https://www.nasdaq.com/market-activity/stocks/ZEAL/news-headlines
625,ZGNX,Zogenix Inc.,https://www.nasdaq.com/market-activity/stocks/ZGNX/news-headlines
626,ZIOP,ZIOPHARM Oncology Inc,https://www.nasdaq.com/market-activity/stocks/ZIOP/news-headlines
627,ZLAB,Zai Lab Limited,https://www.nasdaq.com/market-activity/stocks/ZLAB/news-headlines
628,ZNTL,Zentalis Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/ZNTL/news-headlines
629,ZSAN,Zosano Pharma Corporation,https://www.nasdaq.com/market-activity/stocks/ZSAN/news-headlines
630,ZYME,Zymeworks Inc.,https://www.nasdaq.com/market-activity/stocks/ZYME/news-headlines
631,ZYNE,Zynerba Pharmaceuticals Inc.,https://www.nasdaq.com/market-activity/stocks/ZYNE/news-headlines
